Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses
NCT ID: NCT05075746
Last Updated: 2024-03-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
302 participants
OBSERVATIONAL
2022-03-08
2023-01-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET
NCT05739656
PMCF Retrospective Study Outcomes of a Monofocal Toric Intraocular Lens
NCT05055076
Observational Prospective Clinical Investigation on Monofocal Toric Intraocular Lens
NCT06250855
Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact Lens
NCT05000164
A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses
NCT06839898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a retrospective chart review for preoperative and postoperative data conducted at least 4 weeks after IOL implantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
enVista Toric 0.9D intra ocular lens
enVista Toric
enVista Toric IOL
enVista non-Toric (spherical) intra ocular lens
enVista non-Toric (spherical)
enVista non-Toric (spherical) IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enVista Toric
enVista Toric IOL
enVista non-Toric (spherical)
enVista non-Toric (spherical) IOL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Implant of enVista Toric IOL and/or enVista non-Toric (spherical) IOL in at least one eye
* Data available at least 4 weeks after IOL implantation
* Eyes must qualify for the 0.9D toric lens based on the Barrett Toric Calculator (flipped axis must be less than 0.2D) (https://ascrs.org/tools/barrett-toric-calculator)
* Study eyes were implanted with the 0.9D toric lens
* Control eyes were not implanted with the 0.9D toric lens and implanted with a spherical (non-toric) equivalent instead
Exclusion Criteria
* BCDVA of 20/25 or worse for the treated eye(s) after the surgery
* Excessive IOL rotation \> 10 degrees (Toric IOLs only) for the treated eye(s) after the surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anya Loncaric
Role: STUDY_DIRECTOR
Bausch Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch Site 01
Calgary, Alberta, Canada
Bausch Site 03
Langley, British Columbia, Canada
Bausch Site 02
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHC-RCR-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.